跳至主要内容
临床试验/NCT03581578
NCT03581578Unknown不适用

VITROS Immunodiagnostic Products hs Troponin I

Ortho-Clinical Diagnostics, Inc.24 个研究点 分布在 1 个国家目标入组 1,630 人开始时间: 2018年6月7日最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,630
试验地点
24
主要终点
Sensitivity and specificity of the VITROS hs Troponin I test

研究概览

简要总结

The purpose of this clinical study is to collect data to substantiate the use of the VITROS hs Troponin I test as an aid in the diagnosis of myocardial infarction (MI). The test is further indicated for risk stratification of mortality, myocardial infarction or coronary revascularization in patients with acute coronary syndrome.

详细描述

A prospective clinical sample collection and cardiac troponin I testing will be conducted in individuals presenting to the Emergency Department (ED) with signs and/or symptoms suggestive of acute coronary syndrome (ACS) at geographically dispersed sites in the US. Individuals who meet the inclusion/exclusion criteria, including having signed an informed consent form will be included in the study.

Clinical and laboratory data will be collected to demonstrate product performance compared to an adjudicated clinical diagnosis.

Sample collection and testing of clinical samples with the VITROS hs Troponin I test will be performed under two separate protocols.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject must be ≥22 years of age at the time of consent.
  • Subject presenting with symptoms suggestive of acute coronary syndrome including chest pain, or chest pain equivalent.
  • Must have an Electrocardiogram (ECG) ordered as part of the subject's standard of care.
  • Subject willing and able to provide informed consent.

排除标准

  • Subject is unable to comply with the study requirements.
  • Any samples which were not obtained under IRB approved protocol.

结局指标

主要结局

Sensitivity and specificity of the VITROS hs Troponin I test

时间窗: VITROS hs Troponin I value at > 6 hours and up to 9 hours

Evaluate the sensitivity and specificity of the VITROS hs Troponin I test result against the adjudicated diagnosis for subjects with acute coronary syndrome (ACS).

次要结局

  • Rule in and rule out myocardial infarction (MI)(VITROS hs Troponin I values from two collection time points (baseline, > 1 hour and up to 2 hours))
  • Risk stratification of subjects(Up to 12 months after last enrollment)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (24)

Loading locations...

相似试验